1.
DNA Methylation and Its Implications and Accessibility for Neuropsychiatric Therapeutics
by Day, Jeremy J
Annual review of pharmacology and toxicology, 2015-01-06, Vol.55 (1), p.591-611
2.
Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria
by Seib, Kate L
Pathogens and disease, 2017-08-31, Vol.75 (6)
3.
Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma
by Kohsaka, Shinji
Cancer letters, 2012, Vol.331 (1), p.68-75
4.
The Role of DNA Methylation in Aging, Rejuvenation, and Age-Related Disease
by Johnson, Adiv A.
Rejuvenation research, 2012-10-01, Vol.15 (5), p.483-494
5.
Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
by Bengtsson, Daniel
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1689-1698
6.
Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype
by Yu, Tianfu
Cancer letters, 2018-10-01, Vol.433, p.210-220
7.
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
by Brandsma, Dieta, MD
The lancet oncology, 2008, Vol.9 (5), p.453-461
8.
Characterization of the NgoAXP: phase-variable type III restriction–modification system in Neisseria gonorrhoeae
by Adamczyk-Poplawska, Monika
FEMS microbiology letters, 2009-11-01, Vol.300 (1), p.25-35
9.
Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1
by Ramalho-Carvalho, João
Cancer letters, 2016, Vol.385, p.150-159
10.
Prenatal Exposures of Male Rats to the Environmental Chemicals Bisphenol A and Di(2-Ethylhexyl) Phthalate Impact the Sexual Differentiation Process
by Abdel-Maksoud, Fatma M
Endocrinology (Philadelphia), 2015-12, Vol.156 (12), p.4672-4683
11.
Epigenetic Drug Discovery: Targeting DNA Methyltransferases
by Foulks, Jason M.
Journal of biomolecular screening, 2012-01, Vol.17 (1), p.2-17
12.
Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells
by Lee, Yong-Kyu
Cancer letters, 2017, Vol.403, p.144-151
13.
Prognostic and Predictive Roles of MGMT Protein Expression and Promoter Methylation in Sporadic Pancreatic Neuroendocrine Neoplasms
by Schmitt, Anja Maria
Neuroendocrinology, 2014-11, Vol.100 (1), p.35-44
14.
Aging-Related Genes in Mesenchymal Stem Cells: A Mini-Review
by Yu, Kyung-Rok
Gerontology (Basel), 2013-10, Vol.59 (6), p.557-563
15.
Identification of an isoschizomer of the HhaI DNA methyltransferase in Mycoplasma arthritidis
by Luo, Wenyi
FEMS microbiology letters, 2009-01-01, Vol.290 (2), p.195-198
16.
Development of vorinostat: Current applications and future perspectives for cancer therapy
by Richon, Victoria M
Cancer letters, 2009, Vol.280 (2), p.201-210
17.
Direct transfer of extended groups from synthetic cofactors by DNA methyltransferases
by Klima auskas, Saulius
Nature chemical biology, 2006-01, Vol.2 (1), p.31-32
18.
DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients
by Venza, Mario
Human pathology, 2016, Vol.60, p.137-146
19.
Comparative assessment of three methods to analyze MGMT methylation status in a series of 350 gliomas and gangliogliomas
by Wang, Leiming
Pathology, research and practice, 2017-12, Vol.213 (12), p.1489-1493
20.
Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
by Kristensen, Lasse S
Journal of neuropathology and experimental neurology, 2016-03, Vol.75 (3), p.246-255
